Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan R Hewett

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Blood|November 6, 2010
Wrapping BCR-ABL: it's in the bagJunia V Melo, Duncan R Hewett
British Journal of Haematology|May 4, 2017
Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myelomaAnkit K Dutta, Duncan R Hewett, J Lynn Fink, et al.
Neoplasia (New York, N.Y.)|August 14, 2014
SAMSN1 is a tumor suppressor gene in multiple myelomaJacqueline E Noll, Duncan R Hewett, Sharon A Williams, et al.
Human Molecular Genetics|December 14, 2004
Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndromeDuncan R Hewett, Alison L Simons, Niamh E Mangan, et al.
FASEB Bioadvances|September 14, 2020
Characterization of the role of Samsn1 loss in multiple myeloma developmentNatasha L Friend, Duncan R Hewett, Vasilios Panagopoulos, et al.
Haematologica|November 5, 2020
Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells <i>in vivo</i>Mara N Zeissig, Duncan R Hewett, Vasilios Panagopoulos, et al.
Neoplasia (New York, N.Y.)|November 2, 2017
DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow MicroenvironmentDuncan R Hewett, Kate Vandyke, David M Lawrence, et al.
Journal of Hematology & Oncology|October 8, 2015
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myelomaJacqueline E Noll, Kate Vandyke, Duncan R Hewett, et al.
Plos One|January 30, 2020
GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in miceNatasha Friend, Jacqueline E Noll, Khatora S Opperman, et al.
Leukemia|July 27, 2018
Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stabilityAnkit K Dutta, J Lynn Fink, John P Grady, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Blood|November 6, 2010
Wrapping BCR-ABL: it's in the bagJunia V Melo, Duncan R Hewett
British Journal of Haematology|May 4, 2017
Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myelomaAnkit K Dutta, Duncan R Hewett, J Lynn Fink, et al.
Neoplasia (New York, N.Y.)|August 14, 2014
SAMSN1 is a tumor suppressor gene in multiple myelomaJacqueline E Noll, Duncan R Hewett, Sharon A Williams, et al.
Human Molecular Genetics|December 14, 2004
Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndromeDuncan R Hewett, Alison L Simons, Niamh E Mangan, et al.
FASEB Bioadvances|September 14, 2020
Characterization of the role of Samsn1 loss in multiple myeloma developmentNatasha L Friend, Duncan R Hewett, Vasilios Panagopoulos, et al.
Haematologica|November 5, 2020
Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells <i>in vivo</i>Mara N Zeissig, Duncan R Hewett, Vasilios Panagopoulos, et al.
Neoplasia (New York, N.Y.)|November 2, 2017
DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow MicroenvironmentDuncan R Hewett, Kate Vandyke, David M Lawrence, et al.
Journal of Hematology & Oncology|October 8, 2015
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myelomaJacqueline E Noll, Kate Vandyke, Duncan R Hewett, et al.
Plos One|January 30, 2020
GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in miceNatasha Friend, Jacqueline E Noll, Khatora S Opperman, et al.
Leukemia|July 27, 2018
Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stabilityAnkit K Dutta, J Lynn Fink, John P Grady, et al.
Pageof 3